EP Patent

EP2615088A1 — Composition, synthesis and use of new substituted pyran and pterin compounds

Assigned to Duquesne University of the Holy Spirit · Expires 2013-07-17 · 13y expired

What this patent protects

The present invention relates to substituted pterin compounds, their synthesis and use. In particular, the present invention relates to a new precursor compound and its analogs for synthesizing a new substituted pterin compound and its analogs. These new compounds are particularl…

USPTO Abstract

The present invention relates to substituted pterin compounds, their synthesis and use. In particular, the present invention relates to a new precursor compound and its analogs for synthesizing a new substituted pterin compound and its analogs. These new compounds are particularly suitable for treating molybdenum cofactor deficiency.

Drugs covered by this patent

Patent Metadata

Patent number
EP2615088A1
Jurisdiction
EP
Classification
—
Expires
2013-07-17
Drug substance claim
No
Drug product claim
No
Assignee
Duquesne University of the Holy Spirit
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.